We are pleased to announce that we are a recipient of a G-Rex? Grant from ScaleReady to support our ongoing efforts to develop off-the-shelf cell therapies for solid tumors, leveraging our proprietary data-driven discovery platforms. This partnership will help us accelerate the internal process development for our CAR and TCR programs, ensuring future scalability and cost-effectiveness of these potentially life-saving therapeutics. We also want to thank Wilson Wolf Manufacturing, LLC, Bio-Techne and CellReady? for their collaboration on the grant program. Please see here for more details: https://lnkd.in/gWzRTST3 #celltherapy #CAR #CART #allogeneic #oncology #drugdevelopment
OverT Bio
生物技术研究
New York，NY 1,298 位关注者
Finding new genes to power transformative cell therapies.
关于我们
Finding new genes to power transformative cell therapies.
- 网站
-
https://www.overt.bio/
OverT Bio的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- New York，NY
- 类型
- 私人持股
地点
-
主要
获取路线
430 E 29th St
US，NY，New York，10016
OverT Bio员工
动态
-
We are happy to announce OverT Bio's collaboration with Nona Biosciences to support our development of next generation cell therapies for solid tumors. At OverT Bio, we are leveraging high-throughput genomics to discover and develop off-the-shelf cellular therapeutics that can lead to meaningfully better outcomes for patients underserved by the current standards of care. By combining our unbiased, data-driven discovery engines and scalable cell engineering process with Nona's fully human HCAb platform, we are poised to accelerate the development of our lead program towards first-in-human proof of concept studies. For more details please see: https://lnkd.in/geCKdqpA #celltherapy #CART #oncology #allogeneic
-
?? Congratulations to Dr Mat Legut, CEO of OverT Bio, on the company's debut with strong backing! ?? Exciting news as they embark on a journey to explore new avenues for advancing solid cancer cell therapies. ?? Wishing Dr Legut and the entire team at OverT Bio continued success as they pave the way for innovation in the field. ?? #BioTech #Innovation #CancerResearch #OverTBio #IO360 Immuno-Oncology 360° Community News io360summit.com https://lnkd.in/gr97-7Wh
-
Congrats to Mat Legut, Neville Sanjana, and the team at OverT Bio, who are combining cutting-edge cell engineering technologies with big data approaches to address major unmet medical needs in solid tumors. “Everything OverT does is based on a patient-centric mission and focused on developing therapies that extend and enhance the lives of cancer patients,” said Dr. Vasudev Bailey, partner at ARTIS Ventures. #techbio #biotech #celltherapy
-
Very excited to announce the official launch of OverT Bio with $16M in initial financing. With this capital, we are leveraging high-throughput genomics platforms to develop the optimal cell therapy products for solid tumors. We are committed to bringing curative therapies to patients who have been failed by the current standard of care. https://lnkd.in/ebb3pX4b
-
We are thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers. Our mission: To unleash the curative potential of cell therapies for patients who have been failed by current treatments. https://lnkd.in/e3dmBhrM